These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28368074)

  • 21. Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.
    Petrosillo N; Giannella M; Lewis R; Viale P
    Expert Rev Anti Infect Ther; 2013 Feb; 11(2):159-77. PubMed ID: 23409822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of carbapenem resistance among plasmid-mediated AmpC β-lactamase-producing Klebsiella pneumoniae during outbreaks in liver transplantation units.
    Matsumura Y; Tanaka M; Yamamoto M; Nagao M; Machida K; Ito Y; Takakura S; Ogawa K; Yoshizawa A; Fujimoto Y; Okamoto S; Uemoto S; Ichiyama S
    Int J Antimicrob Agents; 2015 Jan; 45(1):33-40. PubMed ID: 25455850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tigecycline for carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit.
    Vardakas KZ; Matthaiou DK; Falagas ME; Antypa E; Koteli A; Antoniadou E
    Infect Dis (Lond); 2015; 47(10):751-3. PubMed ID: 25986909
    [No Abstract]   [Full Text] [Related]  

  • 24. Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.
    Iraz M; Özad Düzgün A; Sandallı C; Doymaz MZ; Akkoyunlu Y; Saral A; Peleg AY; Özgümüş OB; Beriş FŞ; Karaoğlu H; Çopur Çiçek A
    Ann Lab Med; 2015 Nov; 35(6):595-601. PubMed ID: 26354347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience.
    Lübbert C; Faucheux S; Becker-Rux D; Laudi S; Dürrbeck A; Busch T; Gastmeier P; Eckmanns T; Rodloff AC; Kaisers UX
    Int J Antimicrob Agents; 2013 Dec; 42(6):565-70. PubMed ID: 24100228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.
    Benenson S; Navon-Venezia S; Carmeli Y; Adler A; Strahilevitz J; Moses AE; Block C
    Int J Infect Dis; 2009 Sep; 13(5):e295-8. PubMed ID: 19329345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance.
    Adler A; Ben-Dalak M; Chmelnitsky I; Carmeli Y
    Antimicrob Agents Chemother; 2015 Aug; 59(8):5014-7. PubMed ID: 25987630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections.
    Ben-David D; Kordevani R; Keller N; Tal I; Marzel A; Gal-Mor O; Maor Y; Rahav G
    Clin Microbiol Infect; 2012 Jan; 18(1):54-60. PubMed ID: 21722257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Klebsiella necrotizing soft tissue infections in liver transplant recipients: a case series.
    Rana MM; Sturdevant M; Patel G; Huprikar S
    Transpl Infect Dis; 2013 Aug; 15(4):E157-63. PubMed ID: 23782431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors.
    Budak S; Oncul O; Aktas Z; Acar A; Ozyurt M; Turhan V; Erdem H; Gorenek L
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):113-22. PubMed ID: 24964660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First identified case of VIM-producing carbapenem-resistant Klebsiella pneumoniae in the Republic of Ireland associated with fatal outcome.
    Prior AR; Roche C; Lynch M; Kelly S; O'Rourke K; Crowley B
    Euro Surveill; 2010 Dec; 15(50):. PubMed ID: 21172170
    [No Abstract]   [Full Text] [Related]  

  • 32. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae.
    Kochar S; Sheard T; Sharma R; Hui A; Tolentino E; Allen G; Landman D; Bratu S; Augenbraun M; Quale J
    Infect Control Hosp Epidemiol; 2009 May; 30(5):447-52. PubMed ID: 19301985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.
    Borer A; Saidel-Odes L; Riesenberg K; Eskira S; Peled N; Nativ R; Schlaeffer F; Sherf M
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):972-6. PubMed ID: 19712030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
    Netikul T; Kiratisin P
    PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients.
    Barchiesi F; Montalti R; Castelli P; Nicolini D; Staffolani S; Mocchegiani F; Fiorentini A; Manso E; Vivarelli M
    BMC Infect Dis; 2016 Oct; 16(1):538. PubMed ID: 27716164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit.
    Sbrana F; Malacarne P; Viaggi B; Costanzo S; Leonetti P; Leonildi A; Casini B; Tascini C; Menichetti F
    Clin Infect Dis; 2013 Mar; 56(5):697-700. PubMed ID: 23155147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery.
    Salsano A; Giacobbe DR; Sportelli E; Olivieri GM; Brega C; Di Biase C; Coppo E; Marchese A; Del Bono V; Viscoli C; Santini F
    Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):762-768. PubMed ID: 27371609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
    J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement.
    Girmenia C; Viscoli C; Piciocchi A; Cudillo L; Botti S; Errico A; Sarmati L; Ciceri F; Locatelli F; Giannella M; Bassetti M; Tascini C; Lombardini L; Majolino I; Farina C; Luzzaro F; Rossolini GM; Rambaldi A
    Haematologica; 2015 Sep; 100(9):e373-6. PubMed ID: 25862702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.